The Phase 2b study demonstrated a statistically significant dose-response relationship at the primary endpoint following a single administration of MM120 across four dose levels, with improvements ...
Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder
- Recently announced positive Phase 1 topline safety, pharmacokinetic (“PK”) and pharmacodynamic (“PD”) data show that intravenous (“IV”) CYB004 demonstrated robust and rapid-onset psychedelic effects ...
Cognitive behavioral therapy (CBT) should be considered first-line treatment for generalized anxiety disorder in adults, according to a systematic review and network meta-analysis of 66 randomized ...
Recent Phase 1 trial topline results showed positive safety and improved efficacy data for IV administration vs. standard DMT. Following FDA approval, Cybin will commence a randomized, double-blind, ...
CLEVELAND — Researchers narrowed down what appears to be the correct dosage during a first ever rigorous clinical trial examining LSD as a treatment for generalized anxiety disorder, with results ...
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain ...
Please provide your email address to receive an email when new articles are posted on . MM-120 demonstrated clinically and statistically significant reductions in anxiety compared with placebo at 12 ...
A rigorous new study finds that a single dose of LSD can ease anxiety and depression for months. The study involved 198 adults with generalized anxiety disorder, or GAD, a disabling form of anxiety ...
July 12 (UPI) --Mothers to daughters, fathers to sons: That's how anxiety disorders may be transmitted, according to a new study. While anxiety disorders are known to run in families, it remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results